4.5 Article

Design and characterization of digluconate and diacetate chlorhexidine loaded-PLGA microparticles for dental applications

出版社

ELSEVIER
DOI: 10.1016/j.jddst.2021.102361

关键词

PLGA; Chlorhexidine; Dentistry; Controlled release; Stability

资金

  1. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]
  2. PROAP/CAPES
  3. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [504044/2011-7]

向作者/读者索取更多资源

Chlorhexidine solutions are widely used in dentistry for caries prevention and disinfection. This study developed microparticles loaded with chlorhexidine for controlled release in oral health applications. The microparticles showed efficient antibacterial response against Streptococcus mutans, making them a promising alternative for new dental materials with anti-caries properties.
Chlorhexidine solutions are widely used in dentistry, from caries prevention to endodontic disinfection. This biguadine presents a broad spectrum and can be bacteriostatic/bactericide depending on the concentration and time-lapse used. Chlorhexidine diacetate (CDA) and digluconate (CDG) are the most common salts used in dental practice. While CDA saturation occurs at 2%, CDG presents higher solubity and is therefore used as diluted solutions or gels. CDG is the antiseptic of choice for oral rinses because it is less likely to irritate mucous membranes. Although it is very efficient in bacterial control, it presents some drawbacks such as teeth and/or restoration staining, taste alterations and tongue discoloration. Therefore, technological improvement is very desirable to promote its sustained release and avoid those issues. This study aimed to develop and characterize microparticles of chlorhexidine loaded poly (D,L-lactide-co-glycolide) (PLGA) for dental applications. CDA and CDG microparticles were prepared by spray-drying technique and characterized in terms of particle size, polydispersity (pdI), morphology, stability, yield of production, encapsulation efficacy (EE), drug loading (DL), cumulative release and antibacterial response. The yield of production showed the best result for CDA (over 71.56%). Morphological appreciation showed homogenous, spherical and non-aggregated microparticles. Particle size ranged from 1.01 to 3.07 mu m, while pdI remained below 0.3. The microencapsulation process resulted in EE in the range of 7.05?34.72% and DL between 0.41 and 4.08%. The microencapsulation resulted in a controlled release pattern for both salts. CDA microparticles presented a more sustained pattern, while CDG presented a more pronounced burst effect. Finally, CDA and CDG content of the microparticles were able to inhibit Streptococcus mutans in vitro. Accordingly, the PLGA-based microparticles represent a suitable alternative for oral health applications where CDA and CDG in the solid-state and a controlled release pattern of chlorhexidine up to 120 days is strategic, such as in the composition of new dental materials with anti-caries properties.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据